NCT05000086View on ClinicalTrials.gov

A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2019

Primary Completion Date

July 1, 2021

Study Completion Date

July 1, 2021

Conditions
Arthritis, Psoriatic
Interventions
DRUG

99Tc methylene diphosphonate

22mg qd，Once a day for 7 consecutive days

Trial Locations (1)

100730

Peking Union Medical College hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Chengdu Yunke Pharmaceutical Co., Ltd.

UNKNOWN

lead

Peking Union Medical College Hospital

OTHER